Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE
Katrina Walker(University of Leeds), Alastair Greystoke(Newcastle University), Rachel Phillip(University of Leeds), Jamie B. Oughton, Anthony J. Chalmers(Beatson West of Scotland Cancer Centre), Sarah Brown(University of Leeds), Samantha Hinsley(University of Leeds), Corinne Faivre‐Finn(University of Manchester), Geraldine Murden(University of Leeds)
Cited by 4
Related Papers
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
|New England Journal of Medicine|2007|1.1k
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640